These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25370037)

  • 1. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
    Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
    Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.
    Stacey SN; Sulem P; Zanon C; Gudjonsson SA; Thorleifsson G; Helgason A; Jonasdottir A; Besenbacher S; Kostic JP; Fackenthal JD; Huo D; Adebamowo C; Ogundiran T; Olson JE; Fredericksen ZS; Wang X; Look MP; Sieuwerts AM; Martens JW; Pajares I; Garcia-Prats MD; Ramon-Cajal JM; de Juan A; Panadero A; Ortega E; Aben KK; Vermeulen SH; Asadzadeh F; van Engelenburg KC; Margolin S; Shen CY; Wu PE; Försti A; Lenner P; Henriksson R; Johansson R; Enquist K; Hallmans G; Jonsson T; Sigurdsson H; Alexiusdottir K; Gudmundsson J; Sigurdsson A; Frigge ML; Gudmundsson L; Kristjansson K; Halldorsson BV; Styrkarsdottir U; Gulcher JR; Hemminki K; Lindblom A; Kiemeney LA; Mayordomo JI; Foekens JA; Couch FJ; Olopade OI; Gudbjartsson DF; Thorsteinsdottir U; Rafnar T; Johannsson OT; Stefansson K
    PLoS Genet; 2010 Jul; 6(7):e1001029. PubMed ID: 20661439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk.
    Yang Z; Shen J; Cao Z; Wang B
    Breast Cancer Res Treat; 2013 May; 139(1):267-75. PubMed ID: 23609471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
    Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
    Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
    Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
    Dunbier AK; Anderson H; Ghazoui Z; Lopez-Knowles E; Pancholi S; Ribas R; Drury S; Sidhu K; Leary A; Martin LA; Dowsett M
    PLoS Genet; 2011 Apr; 7(4):e1001382. PubMed ID: 21552322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
    Dunning AM; Michailidou K; Kuchenbaecker KB; Thompson D; French JD; Beesley J; Healey CS; Kar S; Pooley KA; Lopez-Knowles E; Dicks E; Barrowdale D; Sinnott-Armstrong NA; Sallari RC; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Hills M; Jarosz M; Drury S; Canisius S; Bolla MK; Dennis J; Wang Q; Hopper JL; Southey MC; Broeks A; Schmidt MK; Lophatananon A; Muir K; Beckmann MW; Fasching PA; Dos-Santos-Silva I; Peto J; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; González-Neira A; Perez JI; Anton-Culver H; Eunjung L; Arndt V; Brenner H; Meindl A; Schmutzler RK; Brauch H; Hamann U; Aittomäki K; Blomqvist C; Ito H; Matsuo K; Bogdanova N; Dörk T; Lindblom A; Margolin S; Kosma VM; Mannermaa A; Tseng CC; Wu AH; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Peterlongo P; Radice P; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Goldberg MS; Teo SH; Yip CH; Nord S; Borresen-Dale AL; Kristensen V; Long J; Zheng W; Pylkäs K; Winqvist R; Andrulis IL; Knight JA; Devilee P; Seynaeve C; Figueroa J; Sherman ME; Czene K; Darabi H; Hollestelle A; van den Ouweland AM; Humphreys K; Gao YT; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Ghoussaini M; Perkins BJ; Shah M; Choi JY; Kang D; Lee SC; Hartman M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Brennan P; Sangrajrang S; Ambrosone CB; Toland AE; Shen CY; Wu PE; Orr N; Swerdlow A; McGuffog L; Healey S; Lee A; Kapuscinski M; John EM; Terry MB; Daly MB; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Neuhausen SL; Ejlertsen B; Hansen TV; Osorio A; Benitez J; Rando R; Weitzel JN; Bonanni B; Peissel B; Manoukian S; Papi L; Ottini L; Konstantopoulou I; Apostolou P; Garber J; Rashid MU; Frost D; ; Izatt L; Ellis S; Godwin AK; Arnold N; Niederacher D; Rhiem K; Bogdanova-Markov N; Sagne C; Stoppa-Lyonnet D; Damiola F; ; Sinilnikova OM; Mazoyer S; Isaacs C; Claes KB; De Leeneer K; de la Hoya M; Caldes T; Nevanlinna H; Khan S; Mensenkamp AR; ; Hooning MJ; Rookus MA; Kwong A; Olah E; Diez O; Brunet J; Pujana MA; Gronwald J; Huzarski T; Barkardottir RB; Laframboise R; Soucy P; Montagna M; Agata S; Teixeira MR; ; Park SK; Lindor N; Couch FJ; Tischkowitz M; Foretova L; Vijai J; Offit K; Singer CF; Rappaport C; Phelan CM; Greene MH; Mai PL; Rennert G; Imyanitov EN; Hulick PJ; Phillips KA; Piedmonte M; Mulligan AM; Glendon G; Bojesen A; Thomassen M; Caligo MA; Yoon SY; Friedman E; Laitman Y; Borg A; von Wachenfeldt A; Ehrencrona H; Rantala J; Olopade OI; Ganz PA; Nussbaum RL; Gayther SA; Nathanson KL; Domchek SM; Arun BK; Mitchell G; Karlan BY; Lester J; Maskarinec G; Woolcott C; Scott C; Stone J; Apicella C; Tamimi R; Luben R; Khaw KT; Helland Å; Haakensen V; Dowsett M; Pharoah PD; Simard J; Hall P; García-Closas M; Vachon C; Chenevix-Trench G; Antoniou AC; Easton DF; Edwards SL
    Nat Genet; 2016 Apr; 48(4):374-86. PubMed ID: 26928228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa.
    Shahzad S; Khan NU; Sombal W; Shah RU; Khan AU; Iqbal A; Munir I
    Mol Biol Rep; 2023 Mar; 50(3):2445-2451. PubMed ID: 36595122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
    Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.
    Sun Y; Ye C; Guo X; Wen W; Long J; Gao YT; Shu XO; Zheng W; Cai Q
    Carcinogenesis; 2016 Feb; 37(2):163-168. PubMed ID: 26645718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
    Dehghan Z; Sadeghi S; Tabatabaeian H; Ghaedi K; Azadeh M; Fazilati M; Bagheri F
    Gene; 2017 May; 611():9-14. PubMed ID: 28216037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
    Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
    Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
    Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
    Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.
    Han J; Jiang T; Bai H; Gu H; Dong J; Ma H; Hu Z; Shen H
    Breast Cancer Res Treat; 2011 Oct; 129(3):901-7. PubMed ID: 21528353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
    Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
    Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of associations between ESR1 variants and breast cancer risk in Chinese cohorts.
    Li X; Yao GY; Li FX; Qiu YR; Yang XX
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.